SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Iridex Corp (NASDAQ:IRIX)

US · Delayed Price · Currency is USD
0.66-0.02 (-2.24%)
 
Market Cap11.42M-51.8%
Revenue (ttm)51.57M+3.7%
Net Income-3.55M+34.9%
EPS-0.20+38.2%
Shares Out17.31M
PE Ration/a
Forward PE33.00
Dividendn/a
Ex-Dividend Daten/a
Volume70,417
Open0.65
Previous Close0.68
Day's Range0.65 - 0.67
52-Week Range0.65 - 1.65
Beta0.63
AnalystsBuy
Price Target2.75(+316.67%)
Earnings DateNov 17, 2026
-2.24% (1D)
No price history available.

About IRIX

IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment. For ailments like diabetic macular edema and other retinal pathologies, IRIDEX provides the IQ 532 and IQ 577 laser photocoagulation systems. Furthermore, the OcuLight series, encompassing models such as TX, SL, SLx, GL, and GLx, offers solutions for managing severe retinal issues like proliferative diabetic retinopathy, macular holes, and retinal tears or detachments. Beyond laser consoles, the company also manufactures specialized delivery instruments. These include the TxCell scanning laser delivery system, which empowers clinicians with multi-spot pattern scanning capabilities. A unique slit lamp adapter enables practitioners to integrate standard slit lamps into their diagnostic and therapeutic workflows. Additionally, a laser indirect ophthalmoscope is available for interventions targeting peripheral retinal disorders. IRIDEX's offerings extend to various probes. The MicroPulse P3 Probe, when coupled with the Cyclo G6 laser system, facilitates MicroPulse transscleral laser therapy. For managing uncontrolled glaucoma, the G-Probe is employed, while both the G-Probe and G-Probe Illuminate are utilized in procedures addressing refractory glaucoma. The EndoProbe product line supports a range of vitrectomy procedures. Their diverse client base spans ophthalmology professionals, academic and research hospitals, government healthcare facilities, specialized surgical centers, general hospitals, veterinary clinics, and private medical practices. Product distribution is handled via an internal and independent sales network across the United States, supplemented by independent distributors for its international markets. Originally incorporated in 1989 as IRIS Medical Instruments, Inc., the company adopted the name IRIDEX Corporation in November 1995. Its corporate headquarters are situated in Mountain View, California.

Address
1212 Terra Bella Avenue, Mountain View, CA, 94043, US
Market Cap
11 million
Employees
93
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$8.47K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-2.24%
5 Days
-5.71%
1 Month
-25.83%
6 Months
-50.75%
1 Year
-51.82%

$IRIX stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in IRIX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by IRIX's directors and management

Net Shares Purchased by Insiders−20k−10k02025Q32025Q42026Q12026Q22026Q3

Source: SEC EDGAR (Form 4)

Corporate Lobbying

IRIX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

IRIX Revenue by Segment or Geography

$12.57MTotal
SegmentRevenue% of All
Retina$6.49M51.61%
Cyclo G6$3.92M31.20%
Other$2.16M17.20%

As of: Q3 2026 (Jul 4, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New IRIX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to IRIX from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in IRIX

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$329.52K
VXFVanguard Extended Market ETF$92.45K

Estimated from each fund’s disclosed top holdings × AUM

IRIX Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for IRIX is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from IRIX’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
3
Sells
0
Buy Value
$8.47K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.